| Neuronal circuits of fear extinction C Herry, F Ferraguti, N Singewald, JJ Letzkus, I Ehrlich, A Lüthi European Journal of Neuroscience 31 (4), 599-612, 2010 | 442 | 2010 |
| Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs N Singewald, P Salchner, T Sharp Biological psychiatry 53 (4), 275-283, 2003 | 335 | 2003 |
| Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders N Singewald, C Schmuckermair, N Whittle, A Holmes, KJ Ressler Pharmacology & therapeutics 149, 150-190, 2015 | 326 | 2015 |
| The role of substance P in stress and anxiety responses K Ebner, N Singewald Amino acids 31 (3), 251-272, 2006 | 311 | 2006 |
| Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain K Hefner, N Whittle, J Juhasz, M Norcross, RM Karlsson, LM Saksida, ... Journal of Neuroscience 28 (32), 8074-8085, 2008 | 243 | 2008 |
| Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats K Ebner, NM Rupniak, A Saria, N Singewald Proceedings of the National Academy of Sciences 101 (12), 4280-4285, 2004 | 237 | 2004 |
| Release of neurotransmitters in the locus coeruleus N Singewald, A Philippu Progress in neurobiology 56 (2), 237-267, 1998 | 221 | 1998 |
| Isoform-specific regulation of mood behavior and pancreatic β cell and cardiovascular function by L-type Ca2+ channels MJ Sinnegger-Brauns, A Hetzenauer, IG Huber, E Renström, ... The Journal of clinical investigation 113 (10), 1430-1439, 2004 | 209 | 2004 |
| Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment SB Sartori, N Whittle, A Hetzenauer, N Singewald Neuropharmacology 62 (1), 304-312, 2012 | 207 | 2012 |
| Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glyoxalase-I R Landgraf, MS Keßler, M Bunck, C Murgatroyd, D Spengler, ... Neuroscience & Biobehavioral Reviews 31 (1), 89-102, 2007 | 203 | 2007 |
| Reduced anxiety and improved stress coping ability in mice lacking NPY‐Y2 receptors A Tschenett, N Singewald, M Carli, C Balducci, P Salchner, A Vezzani, ... European Journal of Neuroscience 18 (1), 143-148, 2003 | 199 | 2003 |
| Release of oxytocin in the rat central amygdala modulates stress-coping behavior and the release of excitatory amino acids K Ebner, OJ Bosch, SA Krömer, N Singewald, ID Neumann Neuropsychopharmacology 30 (2), 223-230, 2005 | 192 | 2005 |
| Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain ME Keck, I Sillaber, K Ebner, T Welt, N Toschi, ST Kaehler, N Singewald, ... European Journal of Neuroscience 12 (10), 3713-3720, 2000 | 191 | 2000 |
| Magnesium-deficient diet alters depression-and anxiety-related behavior in mice—influence of desipramine and Hypericum perforatum extract N Singewald, C Sinner, A Hetzenauer, SB Sartori, H Murck Neuropharmacology 47 (8), 1189-1197, 2004 | 186 | 2004 |
| Role of voltage-gated L-type Ca2+ channel isoforms for brain function J Striessnig, A Koschak, MJ Sinnegger-Brauns, A Hetzenauer, ... Biochemical Society Transactions 34 (5), 903-909, 2006 | 179 | 2006 |
| Single dose of L-dopa makes extinction memories context-independent and prevents the return of fear J Haaker, S Gaburro, A Sah, N Gartmann, TB Lonsdorf, K Meier, ... Proceedings of the National Academy of Sciences 110 (26), E2428-E2436, 2013 | 171 | 2013 |
| Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety C Murgatroyd, A Wigger, E Frank, N Singewald, M Bunck, F Holsboer, ... Journal of Neuroscience 24 (35), 7762-7770, 2004 | 168 | 2004 |
| Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone W Wittmann, E Schunk, I Rosskothen, S Gaburro, N Singewald, H Herzog, ... Neuropsychopharmacology 34 (3), 775-785, 2009 | 165 | 2009 |
| Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry N Singewald, T Sharp Neuroscience 98 (4), 759-770, 2000 | 165 | 2000 |
| Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats N Salomé, P Salchner, O Viltart, H Sequeira, A Wigger, R Landgraf, ... Biological psychiatry 55 (7), 715-723, 2004 | 150 | 2004 |
Simone SartoriUniversity of InnsbruckVerified email at uibk.ac.at
